Interleukin-18 gene polymorphisms in tunisian patients with inflammatory bowel disease

Digestion

Volumn 83, Issue 4, 2011, Pages 269-274

  Ben Aleya, Walid ^a   Sfar, Imen ^a   Habibi, Imen ^a   Mouelhi, Leila ^a   Aouadi, Houda ^a   Makhlouf, Mouna ^a   Ayed Jendoubi, Salwa ^a   Najjar, Taoufik ^a   Abdallah, Taeib Ben ^a   Ayed, Khaled ^a   Gorgi, Yousr ^a  

^a CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Crohn's disease; Gene polymorphisms; Inflammatory bowel disease; Interleukin 18; Ulcerative colitis

Indexed keywords

AUTOANTIBODY; INTERLEUKIN 18;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENTERITIS; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TUNISIA; ULCERATIVE COLITIS;

ADULT; AGED; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTERLEUKIN-18; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUNISIA;

EID: 79151473711     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319755     Document Type: Article

References (47)

1. Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205. (Pubitemid 28307304)
2. Podolsky DK: Inflammatory bowel disease. N Engl J Med 2002; 347: 417.
3. Sartor RB, Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 390-407. (Pubitemid 44018812)
4. Xavier RJ, Podolsky DK: Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-434. (Pubitemid 47123518)
5. Ahmad T, Tamboli CP, Jewell D, et al: Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology 2004; 126: 1533-1549. (Pubitemid 38649871)
6. Bonen DK, Cho JH: The genetics of inflammatory bowel disease. Gastroenterology 2003; 124: 521-536. (Pubitemid 36169267)
7. Strater J, Wellisch I, Riedl S, et al: CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology 1997; 113: 160-167
8. Ueyama H, Kiyohara T, Sawada N, et al: High Fas ligand expression on lymphocytes in lesions of ulcerative colitis. Gut 1998; 43: 48-55. (Pubitemid 28335489)
9. Dinarello CA, Fantuzzi G: Interleukin-18 and host defense against infection. J Infect Dis 2003; 187(suppl 2):370-384.
10. Nakahira M, Ahn HJ, Park WR, et al: Synergy of IL-12 and IL-18 for IFN-γ gene expression: IL-12-induced STAT4 contributes to IFN-γ promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J Immunol 2002; 168: 1146-1153. (Pubitemid 34094479)
11. Puren AJ, Fantuzzi G, Gu Y, et al: Interleukin- 18 (IFN-γ -inducing factor) induces IL-8 and IL-1β via TNF-α production from non- CD14+ human blood mononuclear cells. J Clin Invest 1998; 101: 711-721. (Pubitemid 28084257)
12. Nakanishi K, Yoshimoto T, Tsutsui H, et al: Interleukin-18 regulates Th1 and Th2 responses. Annu Rev Immunol 2001; 19: 423-474. (Pubitemid 32368042)
13. Kalina U, Ballas K, Koyama N, et al: Genomic organization and regulation of the human interleukin-18 gene. Scand J Immunol 2000; 52: 525-530. (Pubitemid 32011763)
14. Nolan KF, Greaves DR, Waldmann H: The human interleukin-18 gene IL-18 maps to 11q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci. Genomics 1998; 51: 161-163. (Pubitemid 28373391)
15. Giedraitis V, He B, Huang WX, et al: Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001; 112: 146-152.
16. Kretowski A, Mironczuk K, Karpinska A, et al: Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes 2002; 51: 3347-3349. (Pubitemid 35246985)
17. Ide A, Kawasaki E, Abiru N, et al: Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J Autoimmun 2004; 22: 73-78. (Pubitemid 38050215)
18. Heninger E, Treszl A, Kocsis I, et al: Genetic variants of the interleukin-18 promoter region (-607) influence the course of necrotising enterocolitis in very low birth weight neonates. Eur J Pediatr 2002; 161: 410-411. (Pubitemid 34744020)
19. Takada T, Suzuki E, Morohashi K, et al: Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population. Tissue Antigens 2002; 60: 36-42. (Pubitemid 35177022)
20. Stassen NA, Breit CM, Norfleet LA, et al: IL- 18 promoter polymorphisms correlate with the development of post-injury sepsis. Surgery 2003; 134: 351-356. (Pubitemid 37070360)
21. Sivalingam SP, Yoon KH, Koh DR, et al: Single- nucleotide polymorphisms of the interleukin- 18 gene promoter region in rheumatoid arthritis patients: protective effect of AA genotype. Tissue Antigens 2003; 62: 498-504. (Pubitemid 37475997)
22. Zhang PA, Wu JM, Li Y, et al: Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population. World J Gastroenterol 2005; 11: 1594-1598. (Pubitemid 40520797)
23. Bushley AW, Ferrell R, McDuffie K, et al: Polymorphisms of interleukin (IL)-1α , IL- 1β , IL-6, IL-10, and IL-18 and the risk of ovarian cancer. Gynecol Oncol 2004; 95: 672-679. (Pubitemid 39592536)
24. Cardoso SM, DeFor TE, Tilley LA, et al: Patient interleukin-18 GCG haplotype associates with improved survival and decreased transplant-related mortality after unrelateddonor bone marrow transplantation. Br J Haematol 2004; 126: 704-710. (Pubitemid 39221307)
25. Satsangi J, Parkes M, Louis E, et al: Twostage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nature Genet 1996; 14: 199-202. (Pubitemid 26338804)
26. Lawrance IC, Fiocchi C, Chakravarti S: Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 2001; 10: 445-456. (Pubitemid 32181667)
27. Ide A, Kawasaki E, Abiru N, et al: Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J Autoimmun 2004; 22: 73-78. (Pubitemid 38050215)
28. Sugiura T, Kawaguchi Y, Harigai M, et al: Association between adult-onset Still's disease and interleukin-18 gene polymorphisms. Genes Immun 2002; 3: 394-399. (Pubitemid 41656537)
29. Higa S, Hirano T, Mayumi M, et al: Association between interleukin-18 gene polymorphisms 105A/C and asthma. Clin Exp Allergy 2003; 33: 1097-1102. (Pubitemid 36976236)
30. Novak N, Kruse S, Potreck J, et al: Single nucleotide polymorphisms of the IL-18 gene are associated with atopic eczema. J Allergy Clin Immunol 2005; 115: 828-833. (Pubitemid 40460861)
31. Pizarro TT, Michie MH, Bentz M, et al: IL- 18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J Immunol 1999; 162: 6829-6835. (Pubitemid 29309411)
32. Pages F, Lazar V, Berger A, et al: Analysis of interleukin-18, interleukin-1 converting enzyme and interleukin-18-related cytokines in Crohn's disease lesions. Eur Cytokine Network 2001; 12: 97-104. (Pubitemid 32281195)
33. Kanai T, Watanabe M, Okazawa A, et al: Interleukin- 18 is a potent proliferative factor for intestinal mucosal lymphocytes in Crohn's disease. Gastroenterology 2000; 119: 1514-1523. (Pubitemid 32198677)
34. Takagawa T, Tamura K, Takeda N, et al: Association between IL-18 gene promoter polymorphisms and inflammatory bowel disease in a Japanese population. Inflamm Bowel Dis 2005; 11: 1038-1043. (Pubitemid 41682559)
35. Tamura K, Fukuda Y, Sashio H, et al: IL-18 polymorphism is associated with an increased risk of Crohn's disease. J Gastroenterol 2002; 37(suppl 14):111-116. (Pubitemid 35385941)
36. Gaya DR, Russell RK, Nimmo ER, et al: New genes in inflammatory bowel disease. Lessons for complex disease? Lancet 2006; 367: 1271-84.
37. Hugot JP, Chamaillard M, Zouali H, et al: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's Disease. Nature 2001; 411: 599-603. (Pubitemid 32531408)
38. Yamazaki K, Takazoe M, Tanaka T, et al: Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet 2002; 47: 469-472. (Pubitemid 34988282)
39. Okamura H, Kashiwamura S, Tsutsui H, et al: Regulation of interferon-γ production by IL-12 and IL-18. Curr Opin Immunol 1998; 10: 259-264. (Pubitemid 28286951)
40. Takeda K, Tsutsui H, Yoshimoto T, et al: Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998; 8: 383-390. (Pubitemid 28188898)
41. Wei XQ, Leung BP, Niedbala W, et al: Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. J Immunol 1999; 163: 2821-2828. (Pubitemid 29399211)
42. Okazawa A, Kanai T, Nakamaru K, et al: Human intestinal epithelial cell-derived interleukin (IL)-18, along with IL-2, IL-7 and IL- 15, is a potent synergistic factor for the proliferation of intraepithelial lymphocytes. Clin Exp Immunol 2004; 136: 269-276. (Pubitemid 38543445)
43. Micallef MJ, Tanimoto T, Kohno K, et al: Interleukin- 18 induces a synergistic enhancement of interferon-γ production in mixed murine spleen cell-tumor cell cultures: role of endogenous interleukin-12. Cancer Detect Prev 2000; 24: 234-243. (Pubitemid 30656731)
44. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H: Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001; 12: 53-72. (Pubitemid 32294587)
45. Trinchieri G: Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3: 133-146. (Pubitemid 37328691)
46. Matsuzaki K, Hokari R, Kato S, et al: Differential expression of CCR5 and CRTH2 on infiltrated cells in colonic mucosa of patients with ulcerative colitis. J Gastroenterol Hepatol 2003; 18: 1081-1088. (Pubitemid 37175951)
47. Neuman MG: Immune dysfunction in inflammatory bowel disease. Transl Res 2007; 149: 173-186. (Pubitemid 46442010)